DGS Capital Management LLC Has $815,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

DGS Capital Management LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.3% in the third quarter, HoldingsChannel.com reports. The firm owned 1,659 shares of the medical equipment provider’s stock after buying an additional 268 shares during the period. DGS Capital Management LLC’s holdings in Intuitive Surgical were worth $815,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the stock. ORG Partners LLC lifted its position in Intuitive Surgical by 3,411.1% during the second quarter. ORG Partners LLC now owns 316 shares of the medical equipment provider’s stock valued at $138,000 after purchasing an additional 307 shares during the last quarter. Fiduciary Financial Group LLC purchased a new stake in Intuitive Surgical during the second quarter valued at $394,000. Valley National Advisers Inc. increased its position in Intuitive Surgical by 29.3% in the second quarter. Valley National Advisers Inc. now owns 622 shares of the medical equipment provider’s stock worth $276,000 after buying an additional 141 shares in the last quarter. Miracle Mile Advisors LLC raised its stake in Intuitive Surgical by 13.4% during the 2nd quarter. Miracle Mile Advisors LLC now owns 1,676 shares of the medical equipment provider’s stock valued at $746,000 after purchasing an additional 198 shares during the period. Finally, Pure Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 2.4% in the 2nd quarter. Pure Financial Advisors LLC now owns 1,506 shares of the medical equipment provider’s stock worth $670,000 after buying an additional 35 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock traded down $0.67 during mid-day trading on Friday, hitting $544.05. The stock had a trading volume of 135,018 shares, compared to its average volume of 1,435,599. Intuitive Surgical, Inc. has a fifty-two week low of $320.26 and a fifty-two week high of $556.23. The company’s 50-day simple moving average is $520.67 and its 200-day simple moving average is $477.52. The firm has a market cap of $193.78 billion, a PE ratio of 87.58, a PEG ratio of 5.35 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Finally, Truist Financial upped their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $550.28.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.